The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vistra ITCL (India) Ltd, acting as a Debenture Trustee (not a promoter), has filed a disclosure under SEBI SAST Regulation 29(2) regarding the revocation/release of pledge on 3,76,56,092 equity shares of Thyrocare Technologies, representing 71.06% of the company's total share capital. The release date is September 16, 2025. Before and after this transaction, the underlying shareholding remains unchanged — only the encumbrance (pledge) status changed from encumbered to fully released. Thyrocare's total equity share capital is 5,29,94,447 shares of face value Rs. 10 each. Vistra clarifies that as a trustee, the primary compliance responsibility lies with the lender/debenture holder, and this disclosure is being made out of abundant caution.
Positive for shareholders — a pledge on 71.06% of the company's equity (a very large portion) has been fully released, removing a major encumbrance overhang and signaling reduced credit/collateral risk. However, since the filer is a debenture trustee and not a promoter, this does not indicate any change in ultimate beneficial ownership of the company.